Diabetes :: Novartis’ Galvus efficacious in treating patients with type 2 diabetes
Uncontrolled patients with type 2 diabetes treated with metformin, one of the most prescribed oral medicines for this disease, were four times more likely to achieve recommended blood sugar control levels by adding GalvusĀ® (vildagliptin) to their treatment compared to those who added a placebo, according to new clinical data[1].